Home > News > pSivida gets new European Patents for BioSilicon
March 15th, 2004
pSivida gets new European Patents for BioSilicon
Abstract:
Global nanotechnology company pSivida Limited (PSD) announced today that it’s UK operating subsidiary pSiMedica has been granted a further patent in the European market. Managing director Gavin Rezos said this new European Patent is another important addition to an already strong Intellectual Property portfolio. “This also follows the recent patent granted in the US for potential ‘smart’ drug delivery applications of BioSilicon.”
Source:
egoli
Related News Press |
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||